Clinical Trials
5 trialsNCT06434376 2026-04-28
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07371247 2026-01-27
Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07356466 2026-01-21
FUGES032
Fujian Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023848 2025-06-17
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023861 2025-06-17
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation